Literature DB >> 27625302

Prevalence and lethality among patients with histoplasmosis and AIDS in the Midwest Region of Brazil.

Thaísa C Silva1, Carolina M Treméa1, Ana Laura S A Zara1, Ana Flávia Mendonça2, Cássia S M Godoy2, Carolina R Costa1, Lúcia K H Souza1, Maria R R Silva1.   

Abstract

Histoplasmosis is a systemic mycosis that is considered an important public health problem. In this work, we performed a descriptive, observational, cross-sectional and retrospective study with a secondary data analysis of medical records from 2000 to 2012 at a tertiary hospital. The study sample consisted of 275 patients with laboratory-confirmed Disseminated Histoplasmosis (DH)/AIDS. The results showed that the prevalence of DH associated with AIDS was 4.4%. The majority of patients were young adult men with fever in 84.2%, cough in 63.4%, weight loss in 63.1%, diarrhoea in 44.8% and skin manifestations in 27.6% of patients. In the overall cohort, the CD4 counts were low, but not significantly different in survivors and non-survivors. Higher levels of urea and lower levels of haemoglobin and platelets were observed in non-survivor patients (<.05). The global lethality was 71.3% (196/275). The results with high prevalence and lethality highlight the need to adopt measures to facilitate early diagnosis, proper treatment and improved prognosis.
© 2016 Blackwell Verlag GmbH.

Entities:  

Keywords:  zzm321990AIDSzzm321990; histoplasmosis; prevalence

Mesh:

Substances:

Year:  2016        PMID: 27625302     DOI: 10.1111/myc.12551

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  6 in total

1.  Treating progressive disseminated histoplasmosis in people living with HIV.

Authors:  Marylou Murray; Paul Hine
Journal:  Cochrane Database Syst Rev       Date:  2020-04-28

2.  Case of disseminated histoplasmosis in a HIV-infected patient revealed by nasal involvement with maxillary osteolysis.

Authors:  A C Lehur; M Zielinski; J Pluvy; V Grégoire; S Diamantis; A Bleibtreu; C Rioux; A Picard; D Vallois
Journal:  BMC Infect Dis       Date:  2017-05-05       Impact factor: 3.090

3.  Histoplasmosis, An Underdiagnosed Disease Affecting People Living With HIV/AIDS in Brazil: Results of a Multicenter Prospective Cohort Study Using Both Classical Mycology Tests and Histoplasma Urine Antigen Detection.

Authors:  Diego R Falci; Alexandre A Monteiro; Cassia Ferreira Braz Caurio; Tulio C O Magalhães; Melissa O Xavier; Rossana P Basso; Marineide Melo; Alexandre V Schwarzbold; Paulo Roberto Abrão Ferreira; Jose Ernesto Vidal; João Paulo Marochi; Cassia Silva de Miranda Godoy; Renata de Bastos Ascenco Soares; Aurea Paste; Monica B Bay; Vera Lucia Pereira-Chiccola; Lisandra Serra Damasceno; Terezinha do Menino Jesus Silva Leitão; Alessandro C Pasqualotto
Journal:  Open Forum Infect Dis       Date:  2019-04-13       Impact factor: 3.835

4.  Loop-mediated Isothermal Amplification and nested PCR of the Internal Transcribed Spacer (ITS) for Histoplasma capsulatum detection.

Authors:  Matheus da Silva Zatti; Thales Domingos Arantes; José Alex Lourenço Fernandes; Mônica Baumgardt Bay; Eveline Pipolo Milan; Georggia Fatima Silva Naliato; Raquel Cordeiro Theodoro
Journal:  PLoS Negl Trop Dis       Date:  2019-08-26

5.  Prevalence of Histoplasmosis and Molecular Characterization of Histoplasma species in Patients with Presumptive Pulmonary Tuberculosis in Calabar, Nigeria.

Authors:  Bassey E Ekeng; Rita O Oladele; Ubleni E Emanghe; Ernest A Ochang; Tatfeng Y Mirabeau
Journal:  Open Forum Infect Dis       Date:  2022-07-25       Impact factor: 4.423

Review 6.  Disseminated Histoplasmosis as AIDS-presentation. Case Report and Comprehensive Review of Current Literature.

Authors:  Paola Zanotti; Claudia Chirico; Maurizio Gulletta; Laura Ardighieri; Salvatore Casari; Eugenia Quiros Roldan; Ilaria Izzo; Gabriele Pinsi; Giovanni Lorenzin; Fabio Facchetti; Francesco Castelli; Emanuele Focà
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-07-01       Impact factor: 2.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.